Ryze Rx Tirzepatide Review: Cost, Dead Legal Links & Honest Verdict (2026)

Ryze Rx advertises GLP-1s "from $149/month" on its homepage, but the actual catalog lists $199/month — a direct internal contradiction — and its Terms, Privacy Policy, and HIPAA notice are dead links, disclosing no legal entity, refund policy, or governing law. Every fact here comes from the company's own published program.

A headline price that doesn't match the catalog

Worth flagging directly: Ryze Rx's homepage advertises GLP-1s "from $149/month", but the actual product catalog lists $199/month — a real discrepancy between the marketing headline and the actual price table.

Dead legal links

This is a serious gap worth knowing about: Ryze Rx's Terms, Privacy Policy, and HIPAA notice are all dead links — no legal entity name, refund policy, or governing law is disclosed anywhere accessible on the site.

What Ryze Rx is

Ryze Rx is a prescription telehealth platform, for weight loss, TRT, and peptide therapy, prescribing through board-certified physicians and shipping from US-licensed compounding pharmacies. It offers a broad catalog beyond GLP-1s: TRT plus peptides (BPC-157, sermorelin, NAD+, retatrutide, and more).

What Ryze Rx costs

The catalog lists compounded semaglutide and tirzepatide both at $199/month, with $499/$799 three-month bundles.

The brand-vs-compounded question

Ryze Rx dispenses compounded semaglutide and tirzepatide. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Ryze Rx's real strengths: physician consultation and ongoing clinical support included with each prescription, a broad peptide and TRT catalog, free shipping and 24-hour prescription turnaround, and FSA/HSA eligibility. The trade-offs are significant: Terms, Privacy Policy, and HIPAA notice are all dead links — no legal entity, refund policy, or governing law disclosed, pharmacy partners aren't named, the homepage headline price contradicts the actual catalog, and the on-site "4.9/5, 2,400+ reviews" figure is self-reported, not independently verified. As with any GLP-1 program, and especially one with dead legal-document links, treat this as a real red flag and confirm actual terms before providing payment information; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Ryze Rx's broad catalog is a modest positive, but dead legal-document links and a headline price that contradicts the catalog are real red flags worth weighing seriously before providing payment information. For a provider with genuinely working legal disclosures and consistent pricing, compare it against Rylo Health or RxPros. See our best tirzepatide providers ranking for the full field.